Business

SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement

MARLBOROUGH, Mass., June 02, 2025--SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement.

articleDanaher CorporationJune 2, 20254/company/danaher-corporation/news/sciex-and-evosep-expand-access-to-standardized-proteomics-for-pharma-and-biotech-with-new-reseller-agreement
SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement

About this update from Danaher Corporation

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":240,"url":"https://media.zenfs.com/en/business-wire.com/34d7fa05b3f125660ddf180a96c972b0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/LtHezXeJXEkU2pqxOIOb2g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/34d7fa05b3f125660ddf180a96c972b0","width":480,"height":240},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/mWkAI_jeN8MLk8AkAY2ifw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTMyMDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/34d7fa05b3f125660ddf180a96c972b0","width":480,"height":240}},"lazy":false},{"type":"text","content":"MARLBOROUGH, Mass., June 02, 2025--(BUSINESS WIRE)--SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation (NYSE: DHR), and Evosep Biosystems, a global leader in proteomics solutions, enter a reseller agreement to co-sell SCIEX mass spectrometry systems with the newly announced Evosep Eno, for standardized high-throughput proteomics.","length":388,"tagName":"p"},{"type":"text","content":"The reseller agreement empowers researchers to implement standardized proteomics workflows, delivering a robust LC-MS solution designed to meet the evolving demands of pharmaceutical and biotech companies. With Evosep Eno, researchers gain exceptional throughput, sensitivity, and reproducibility. When combined with SCIEX mass spectrometers—engineered for speed and sensitivity in both quantitative and qualitative analyses—this collaboration ensures access to cutting-edge technology tailored to today’s analytical challenges.","length":528,"tagName":"p"},{"type":"text","content":"The latest research from SCIEX and Evosep, shows that the Evosep Eno provides an >5-fold increase of peptide precursor identifications and an >3-fold increase of protein group identifications, at 500 SPD, when coupled to the new ZenoTOF 8600 system. This enables a greater depth of proteome coverage for large-scale cohort, high-throughput analysis.","length":355,"tagName":"p"},{"type":"text","content":""For the application of proteomics in translational medicine, this extended collaboration between SCIEX and Evosep will further adoption of standardized solutions and make the technology ...

More updates from Danaher Corporation

Danaher CorporationEvosep BiosystemsEvosep Enoreseller agreementmass spectrometrylife scienceproteomics